The increased sensitivity of human cytomegalovirus (HCMV) PCR quantitation in whole blood affects reproductive rate (Ro) measurement

Journal of Virological Methods

Volumn 196, Issue , 2014, Pages 179-184

  Gurtler, Volker ^a,b   Mayall, Barrie C ^a   Wang, Jenny ^a   Ghaly Derias, Shahbano ^a  

^a AUSTIN HOSPITAL   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Human cytomegalovirus; Plasma; Quantitative real time PCR; Whole blood

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; HUMAN CYTOMEGALOVIRUS; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS REPRODUCTIVE RATE;

HUMAN HERPESVIRUS 5;

HCMV; HUMAN CYTOMEGALOVIRUS; INTERNATIONAL UNITS; IU; LIMIT OF QUANTITATION; LOD; LOQ; LOWER LIMIT OF DETECTION; PLASMA; QUANTITATIVE REAL-TIME PCR; R(O); REPRODUCTIVE RATE; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; WB; WHOLE BLOOD;

BASIC REPRODUCTION NUMBER; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84889670603     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.10.043     Document Type: Article

References (23)

1. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
2. Bliss C.I. The method of probits. Science 1934, 79:38-39.
3. Burd E.M. Validation of laboratory-developed molecular assays for infectious diseases. Clin. Microbiol. Rev. 2010, 23:550-576.
4. Emery V.C., Griffiths P.D. Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8039-8044.
5. Emery V.C., Cope A.V., Bowen E.F., Gor D., Griffiths P.D. The dynamics of human cytomegalovirus replication in vivo. J. Exp. Med. 1999, 190:177-182.
6. Emery V.C., Sabin C.A., Cope A.V., Gor D., Hassan-Walker A.F., Griffiths P.D. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000, 355:2032-2036.
7. Emery V.C., Hassan-Walker A.F., Burroughs A.K., Griffiths P.D. Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J. Infect. Dis. 2002, 185:1723-1728.
8. Garrigue I., Doussau A., Asselineau J., Bricout H., Couzi L., Rio C., Merville P., Fleury H., Lafon M.-E., Thiebaut R. Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients. J. Clin. Microbiol. 2008, 46:493-498.
9. Habbal W., Monem F., Gartner B.C. Comparative evaluation of published cytomegalovirus primers for rapid real-time PCR: which are the most sensitive?. J. Med. Microbiol. 2009, 58:878-883.
10. Heesterbeek J.A. A brief history of R0 and a recipe for its calculation. Acta Biotheor. 2002, 50:189-204.
11. Jalal H., Stephen H., Curran M.D., Burton J., Bradley M., Carne C. Development and validation of a rotor-gene real-time PCR assay for detection, identification, and quantification of Chlamydia trachomatis in a single reaction. J. Clin. Microbiol. 2006, 44:206-213.
12. Koidl C., Bozic M., Marth E., Kessler H.H. Detection of CMV DNA: is EDTA whole blood superior to EDTA plasma?. J. Virol. Methods 2008, 154:210-212.
13. Kraft C.S., Armstrong W.S., Caliendo A.M. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin. Infect. Dis. 2012, 54:1793-1797.
14. Lautenschlager I. CMV infection, diagnosis and antiviral strategies after liver transplantation. Transplant Int. 2009, 22:1031-1040.
15. Lisboa L.F., Asberg A., Kumar D., Pang X., Hartmann A., Preiksaitis J.K., Pescovitz M.D., Rollag H., Jardine A.G., Humar A. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation 2011, 91:231-236.
16. Nesbitt S.E., Cook L., Jerome K.R. Cytomegalovirus quantitation by real-time PCR is unaffected by delayed separation of plasma from whole blood. J. Clin. Microbiol. 2004, 42:1296-1297.
17. Pillet S., Bourlet T., Pozzetto B. Comparative evaluation of the QIAsymphony RGQ system with the easyMAG/R-gene combination for the quantitation of cytomegalovirus DNA load in whole blood. Virol. J. 2012, 9:231.
18. Qiagen QIAsymphony RGQ Application Sheet artus CMV QS-RGQ Kit (sample-type: plasma) 2012.
19. Razonable R.R., Asberg A., Rollag H., Duncan J., Boisvert D., Yao J.D., Caliendo A.M., Humar A., Do T.D. Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the world health organization international standard is predictive of CMV disease resolution in transplant recipients. Clin. Infect. Dis. 2013, 56:1546-1553.
20. Sakuma M. Probit analysis of preference data. Appl. Entomol. Zool. 1998, 33:339-348.
21. Sanchez J.L., Storch G.A. Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J. Clin. Microbiol. 2002, 40:2381-2386.
22. Schnepf N., Scieux C., Resche-Riggon M., Feghoul L., Xhaard A., Gallien S., Molina J.M., Socie G., Viglietti D., Simon F., Mazeron M.C., Legoff J. Fully Automated Quantification of Cytomegalovirus (CMV) in Whole Blood with the New Sensitive Abbott RealTime CMV Assay in the Era of the CMV International Standard. J. Clin. Microbiol. 2013, 51:2096-2102.
23. von Muller L., Hinz J., Bommer M., Hampl W., Kluwick S., Wiedmann M., Bunjes D., Mertens T. CMV monitoring using blood cells and plasma: a comparison of apples with oranges?. Bone Marrow Transplant. 2007, 39:353-357.